产品
编 号:F270486
分子式:C19H25Cl2N7
分子量:422.35
产品类型
规格
价格
是否有货
结构图
联系客服
产品详情
生物活性:
SKOG102 is a potent OLIG2 inhibitor that is directly engaging OLIG2 and interferes with the ability of OLIG2 to bind DNA. SKOG102 can be used for the research of glioblastoma (GBM).

体内研究:
SKOG102 (10-20 mg/kg; i.p.) 抑制小鼠 GBM4 肿瘤的生长。SKOG102 (5 mg/kg; i.p.) 即使在相对较短的时间内也会在肿瘤中积聚,注射小鼠后 4 小时血浆和脑浓度几乎相同。Animal Model:NSG mice were inoculated in each flank with GBM4 cells
Dosage:10, 15, and 20 mg/kg; dissolved in solutol:PEG400:water (20%:40%:40%)
Administration:Intraperitoneal injection; first 2 weeks (from day 33 to 46) 10 mg/kg, third week (from day 47 to 54) 15 mg/kg, fourth week (from 55 to 66) first 3 days 20 mg/kg, 2 days break, then alternate days from day 60 to 66
Result:Significantly attenuated tumor growth.

体外研究:
SKOG102 (0.1-5 μM; 72 h) 抑制人 GBM4 和 GBM8 细胞生长为神经球,IC50 分别为 10.66 和 1.536 μM。SKOG102 (0.5-5 μM; 12 h) 增加 GBM4 细胞中的 p21 RNA 水平并降低 OMG RNA 水平。SKOG102 (5 μM; 20 h) 抑制 OLIG2-DNA 结合,并降低 GBM8 细胞中的丝氨酸磷酸化 OLIG2 和总 OLIG2 蛋白水平。
产品资料